Bio-Rad Labs (BIO) Tops Q1 EPS by $1.54
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $375.19 -0.47%
EPS Growth %: +5.3%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +5.3%
Financial Fact:
Net income attributable to Bio-Rad: 18.01M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $4.94, $1.54 better than the analyst estimate of $3.40. Revenue for the quarter came in at $700 million versus the consensus estimate of $675.1 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle reports earnings today: AI spending bet faces its toughest test yet
- Designer Brands Inc. (DBI) Tops Q2 EPS by 8c, Misses on Revenue; Offers FY27 EPS Guidance
- Vince Holding (VNCE) Tops Q2 EPS by 86c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
